Delivery Order SPE2DB22D1103-SPE2DB24FTGT0
Award Date 3/19/24
Potential Completion Date 3/20/24
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ROTARIX vaccine oral syringes. The $3,660.63 delivery order has a completion date of January 29, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe format (1.5 mL) under a firm fixed price contract valued at $11,884.18. The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a non-competitive, non-set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order worth $40,202.40 to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4,565,161,303 units of the ROTARIX vaccine oral syringe, 1.5 mL. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical...
- The Defense Logistics Agency (DLA) awarded a $3,893.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringe 1.5ml, with an ultimate completion date of December 3, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a $31.3K firm fixed price delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5ml) with an ultimate completion date of September 3, 2025. This competitively awarded, non-set-aside contract reflects AmerisourceBergen's ongoing role as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery order was performed at...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide ROTARIX Vaccine oral syringes. The $2,929.56 contract has a performance period through March 18, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for this award. No set-aside designation was used....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,504.45 to AmerisourceBergen Drug Corp for Rotarix Vaccine oral syringes (1.5 mL) on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price contract utilizes no set-aside designation and represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is located in...
- The Defense Logistics Agency awarded a $7,507.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Rotarix vaccine in oral syringe format (1.5mL units). The contract, which is scheduled for completion by December 10, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This award was competitively awarded with no set-aside designation. AmerisourceBergen,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the ROTARIX vaccine in oral syringes. The contract has a ceiling value of $1,514.90 and a period of performance through December 30, 2024. It is a firm-fixed price contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a $36,109.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of the ROTARIX VACCINE ORAL SYRINGE 1.5ML. This delivery order was issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTGT0Delivery Order
This firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation, provides the Rotarix vaccine in oral syringes to DLA Troop Support Medical. The $3,661.95 contract has a performance period through March 2024 and is not associated with any set-aside designations. In addition to this delivery order, AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to supply pharmaceuticals and medical supplies to the Department of Defense.
Generated 6/18/24, 2:58 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 3/19/24 |